SAN JOSE, Calif., April 22 /PRNewswire-FirstCall/ -- VNUS(R) Medical Technologies, Inc. (Nasdaq: VNUS), a leading provider of medical devices for the minimally invasive treatment of peripheral vascular disease, explains interruption of its first-quarter 2008 teleconference and webcast held yesterday at 2:00 p.m. PT/5:00 p.m./ET. As a result of teleconference vendor communications difficulties, the Question-and-Answer period did not take place as planned.
Interested parties are encouraged to review the company's news release on its first-quarter 2008 financial results and to listen to either the telephonic replay (719-457-0820, code number 4678111) or audio webcast of the prepared remarks by management archived on the company's website at http://ir.vnus.com/. If anyone has questions, they're invited to contact the company at email@example.com.
About VNUS Medical Technologies, Inc.
VNUS is a leading provider of medical devices for the minimally invasive treatment of venous reflux disease, a progressive condition that is often the underlying cause of painful varicose veins. VNUS sells the Closure(R) system, which consists of a proprietary radiofrequency (RF) generator and proprietary disposable endovenous catheters and devices to close diseased veins through the application of temperature-controlled RF energy. Approximately 300,000 patients have been treated to date with VNUS Closure catheters. For more information, please visit the corporate website at http://www.vnus.com .
|SOURCE VNUS Medical Technologies, Inc.|
Copyright©2008 PR Newswire.
All rights reserved